BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9533166)

  • 1. The pharmacology of native N-methyl-D-aspartate receptor subtypes: different receptors control the release of different striatal and spinal transmitters.
    Nankai M; Klarica M; Fage D; Carter C
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jan; 22(1):35-64. PubMed ID: 9533166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: eliprodil, ifenprodil and other native NMDA receptor subtype selective compounds.
    Nankai M; Klarica M; Fage D; Carter C
    Neurochem Int; 1996 Nov; 29(5):529-42. PubMed ID: 8939463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal NMDA receptor subtypes: the pharmacology of N-methyl-D-aspartate-evoked dopamine, gamma-aminobutyric acid, acetylcholine and spermidine release.
    Nankai M; Fage D; Carter C
    Eur J Pharmacol; 1995 Nov; 286(1):61-70. PubMed ID: 8566152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of N-methyl-D-aspartate-evoked [3H]noradrenaline release in adult rat spinal cord.
    Klarica M; Fage D; Carter C
    Eur J Pharmacol; 1996 Jul; 308(2):135-44. PubMed ID: 8840124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA receptor subtype selectivity: eliprodil, polyamine spider toxins, dextromethorphan, and desipramine selectively block NMDA-evoked striatal acetylcholine but not spermidine release.
    Nankai M; Fage D; Carter C
    J Neurochem; 1995 May; 64(5):2043-8. PubMed ID: 7722489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of NMDA-stimulated [14C]GABA and [3H]acetylcholine release by striatal glutamate and dopamine receptors.
    Hanania T; Johnson KM
    Brain Res; 1999 Oct; 844(1-2):106-17. PubMed ID: 10536266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMDA receptors with different sensitivities to magnesium and ifenprodil control the release of [14C]acetylcholine and [3H]spermidine from rat striatal slices in vitro.
    Nicolas C; Fage D; Carter C
    J Neurochem; 1994 May; 62(5):1835-9. PubMed ID: 7908945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-methyl-D-aspartate-evoked release of [3H]acetylcholine in striatal compartments of the rat: regulatory roles of dopamine and GABA.
    Blanchet F; Kemel ML; Gauchy C; Desban M; Perez S; Glowinski J
    Neuroscience; 1997 Nov; 81(1):113-27. PubMed ID: 9300405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both ethanol and ifenprodil inhibit NMDA-evoked release of various neurotransmitters at different, yet proportional potency: potential relation to NMDA receptor subunit composition.
    Fink K; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):312-9. PubMed ID: 8878061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
    Abarca J; Bustos G
    Neurochem Int; 1999 Jul; 35(1):19-33. PubMed ID: 10403427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspartate as a selective NMDA receptor agonist in cultured cells from the avian retina.
    Kubrusly RC; de Mello MC; de Mello FG
    Neurochem Int; 1998 Jan; 32(1):47-52. PubMed ID: 9460701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil.
    Chizh BA; Reissmüller E; Schlütz H; Scheede M; Haase G; Englberger W
    Neuropharmacology; 2001; 40(2):212-20. PubMed ID: 11114400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotrophin modulation of NMDA receptors in cultured murine and isolated rat neurons.
    Jarvis CR; Xiong ZG; Plant JR; Churchill D; Lu WY; MacVicar BA; MacDonald JF
    J Neurophysiol; 1997 Nov; 78(5):2363-71. PubMed ID: 9356388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methyl-D-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH and protein kinase C inhibition.
    Pittaluga A; Pattarini R; Feligioni M; Raiteri M
    J Neurochem; 2001 Jan; 76(1):139-48. PubMed ID: 11145986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
    Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
    Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.
    Avenet P; Léonardon J; Besnard F; Graham D; Depoortere H; Scatton B
    Neurosci Lett; 1997 Feb; 223(2):133-6. PubMed ID: 9089691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control by GABA and tachykinins of the evoked release of acetylcholine in striatal compartments under different modalities of NMDA receptor stimulation.
    Blanchet F; Gauchy C; Pérez S; Soubrié P; Glowinski J; Kemel ML
    Brain Res; 2000 Jan; 853(1):142-50. PubMed ID: 10627318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of the NMDA receptor modulating hypoxia/hypoglycaemia-induced rat striatal dopamine release in vitro.
    Toner CC; Stamford JA
    Eur J Pharmacol; 1997 Dec; 340(2-3):133-43. PubMed ID: 9537807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of striatal dopamine release by glycine transport inhibitors.
    Javitt DC; Hashim A; Sershen H
    Neuropsychopharmacology; 2005 Apr; 30(4):649-56. PubMed ID: 15688094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.